Orthofix Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Entered Into a New-credit Agreement Worth up to $275 Million. Additionally, Stifel Upgraded the Stock From Hold to Buy and Raised Its...
Orthofix Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Entered Into a New-credit Agreement Worth up to $275 Million. Additionally, Stifel Upgraded the Stock From Hold to Buy and Raised Its...
orthofix medical股票交易高漲，該公司報告了好於預期的Q3財務業績，並簽署了一項價值高達$27500萬的新授信協議。此外，斯蒂費爾將該股票從持有升級爲買入，並提高了其...
Orthofix Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Entered Into a New-credit Agreement Worth up to $275 Million. Additionally, Stifel Upgraded the Stock From Hold to Buy and Raised Its Price Target From $18 to $24 While Roth MKM Raised Its Price Target From $20 to $22.
orthofix medical股票交易較高，因該公司報告第三季度財務結果好於預期，並達成新的信貸協議，價值高達27500萬美元。此外，斯提費爾將股票評級由持有提升爲買入，並將價格目標從18美元提高到24美元，而羅斯MKm將價格目標從20美元提高到22美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。